期刊文献+

早老素增强子-2在APP/PS1双转基因小鼠脑内的分布及表达 被引量:1

Expression and distribution of presenilin enhancer-2 in brain of APP/PS1 double transgenic mice
原文传递
导出
摘要 目的研究γ-分泌酶组件早老素增强子-2(presenilin enhancer-2,Pen-2)在APP/PS1双转基因小鼠脑内的表达及分布,以进一步明确Pen-2与阿尔茨海默病(Alzheimer’s disease,AD)的关系。方法对APP/PS1双转基因小鼠交配后产下的子代进行基因分型,用免疫组化方法检测Pen-2和老年斑在APP/PS1双转基因AD模型小鼠和同窝野生型正常小鼠脑内的分布和表达情况。结果 Pen-2广泛分布于APP/PS1双转基因小鼠脑内各区域,包括大脑皮质、海马、基底核、小脑、嗅脑、脑室脉络丛等,而老年斑则选择性地出现在大脑皮质、海马、嗅脑等区域,并且Pen-2的分布范围广于老年斑的分布。AD模型小鼠大脑新皮质内Pen-2阳性神经元的着色程度(2.09±0.33)显著高于正常小鼠(1.29±0.31,P<0.05),且AD模型小鼠大脑新皮质内Pen-2免疫阳性物质主要分布于细胞膜和细胞质,而正常小鼠大脑新皮质内的Pen-2阳性神经元仅细胞膜周围染色较深,而细胞质染色极浅甚至不着色。结论 Pen-2在AD模型小鼠和正常小鼠脑内的表达存在差异,这种差异可能与老年斑的形成和AD的发生相关。 Objective To examine the expression and distribution of presenilin enhancer-2 (Pen-2), an essential component of γ-secretase complex, in the brain of APP/PS1 double transgenic mice, so as to clarify the relationship between Pen-2 and Alzheimer' s disease (AD). Methods Offspring which were bred by APP/PS1 double transgenic AD mice were genotyped. Immunohistochemical staining was used to check the distribution and expression of Pen-2 in the brain of 8-month-old APP/PS1 double transgenic AD model mice and its age-matched wild-type littermates. Results Pen-2 was widely expressed throughout almost all the regions of brain in APP/PS1 double transgenic mice, including the cerebral cortex, hippocampus, basal nuclei, rhinencephalon, cerebellum, brainstem, and so on. While senile plaques (SP) were selectively distributed in the cerebral cortex, hippocampus, and rhinencephalon. The distribution of Pen-2 was much more extensive than that of SP in the brain of AD model mice. Meanwhile, Pen-2-positive neurons in AD model mice (2.09 ± 0. 33) was more dark-stained than that in wildtype controls ( 1.29 ± 0.31 ) ; Furthermore, both the cell membrane and cytoplasm of Pen-2-positive neurons were heavily stained in the AD mice, while in the wildtype littermates, only membrane and its surrounding of Pen-2-positive neurons were relatively dark-stained, and the cytoplasma was mildly or not stained. Conclusion Distribution and expression of Pen-2 in the brain of APP/ PSI double transgenic mouse model is different from its wildtype littermates. These differences may indicate that Pen-2 is tightly related to SP formation and AD pathogenesis.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第24期2479-2483,共5页 Journal of Third Military Medical University
基金 国家自然科学基金(30700885) 教育部“新世纪优秀人才”支持计划(NCET-11-1084) 重庆市首届优秀人才资助计划[渝教人(2009)2号] 留学人员科技活动项目择优资助[渝人社办(2011)235号]~~
关键词 Pen-2 γ-分泌酶β淀粉样蛋白 阿尔茨海默病 presenilin enhancer-2 γ-secretase Alzheimer' s disease
  • 相关文献

参考文献14

  • 1Vagnoni A,Perkinton M S,Gray E H, et al. Calsyntenin-1 mediatesaxonal transport of the amyloid precursor protein and regulates Aj3production[J]. Hum Mol Genet, 2012, 21(13) : 2845 -2854.
  • 2St-George-Hyslop P, Fraser P E. Assembly of the presenilin y-s-secretase compIex[ J]. J Neurochem, 2012,120(Suppl 1) ; 84 -88.
  • 3Zhang H, Ma Q, Zhang Y W, et al. Proteolytic processing ofAlzheimer,s (3-amyloid precursor protein [ J]. J Neurochem, 2012,120(Suppll) :9-21.
  • 4赵蕾,龙志敏,贺桂琼,楚亚楠,宋冲.前咽缺陷蛋白-1在APP/PS1转基因阿尔茨海默病小鼠模型中枢神经系统的分布及表达[J].中华老年医学杂志,2011,30(12):1038-1042. 被引量:1
  • 5龙志敏,赵蕾,贺桂琼,宋冲,楚亚楠.γ-分泌酶组件NCT在痴呆小鼠中枢神经系统的分布及表达[J].中国老年学杂志,2011,31(11):1999-2003. 被引量:4
  • 6赵蕾,龙志敏,贺桂琼,宋冲,楚亚楠.丙戊酸钠对APP/PS1双重转基因小鼠脑组织Tau蛋白的影响[J].第三军医大学学报,2012,34(12):1167-1170. 被引量:2
  • 7Francis R, McGrath G, Zhang J, et al. aph-1 and pen-2 are required forNotch pathway signaling, gamma-secretase cleavage of betaAPP, andpresenilin protein accumulation[ J]. Dev Cell, 2002, 3(1) : 85 -97.
  • 8Luo W J, Wang H, Li H, et al. PEN-2 and APH-1 coordinatelyregulate proteolytic processing of presenilin 1 [ J]. J Biol Chem, 2003,278(10) : 7850 -7854.
  • 9Shiraishi H,Sai X,Wang H Q, al. PEN-2 enhances gamma-cleav-age after presenilin heterodimer formation[ J]. J Neurochem,2004,90(6): 1402-1413.
  • 10Andreoli V,Trecroci F, La-Russa A, et al. Presenilin enhancer-2gene: identification of a novel promoter mutation in a patient with ear-ly-onset familial Alzheimer , s disease. [ J] Alzheimer , s Dement,2011,7(6): 574 -578.

二级参考文献42

  • 1严波,王宁宇.阿尔茨海默病患者的嗅觉功能改变[J].中华老年医学杂志,2005,24(2):120-121. 被引量:7
  • 2Sheng B,Gong K,Niu Y,et al.Inhibition of gamma-secretase activity reduces Abeta production,reduces oxidative stress,increases mitochondrial activity and leads to reduced vulnerability to apoptosis:Implications for the treatment of Alzheimer′s disease[J].Free Radic Biol Med,2009;46(10):1362-75.
  • 3De Strooper B.Aph-1,Pen-2,and nicastrin with presenilin generate an active gamma-secretase complex[J].Neuron,2003;38(1):9-12.
  • 4Herreman A,Serneels L,Annaert W,et al.Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells[J].Nat Cell Biol,2000;2(7):461-2.
  • 5Annaert W,De Strooper B.A cell biological perspective on Alzheimer′s disease[J].Ann Rev Cell Dev Biol,2002;18:25-51.
  • 6Yu G,Nishimura M,Arawaka S,et al.Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing[J].Nature,2000;407(6800):48-54.
  • 7Pardossi-Piquard R,Dunys J,Yu G,et al.Neprilysin activity and expression are controlled by nicastrin[J].J Neurochem,2006;97(4):1052-6.
  • 8Morais VA,Leight S,Pijak DS,et al.Cellular localization of Nicastrin affects amyloid beta species production[J].FEBS Lett,2008;582(3):427-33.
  • 9Hiltunen M,Mannermaa A,Thompson D,et al.Genome-wide linkage disequilibrium mapping of late-onset Alzheimer′s disease in Finland[J].Neurology,2001;57(9):1663-8.
  • 10Li R,Lindholm K,Yang LB,et al.Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer′s disease patients[J].Proc Natl Acad Sci USA,2004;101(10):3632-7.

共引文献4

同被引文献17

  • 1Fu W, Patel A, Jhamandas J H. Amylin receptor: a common pathophysiological target in Alzheimer' s disease and diabetes mellitus[J]. Front Aging Neurosci, 2013, 5: 42. DOI: 10. 3389/fnagi. 2013. 00042.
  • 2Lee H J, Choe Y H, Lee J H, et al. Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome [ J ]. Yonsei Med J, 2011, 52 ( 2 ) : 257 -262. DOI: 10. 3349/ymj. 2011.52.2.257.
  • 3Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer' s disease: progress and problems on the road to therapeutics [J]. Science, 2002, 297 (5580) : 353 - 356. DOI: 10. 1126/science. 1072994.
  • 4Ritzel R A, Meier J J, Lin C Y, et al. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets [ J ]. Dia- betes, 2007, 56(1): 65-71. DOI: 10.2337/db06-0734.
  • 5Knight J A. Disease and disorders associated with excess body weight[J]. Ann Clin Lab Sci, 2011,41(2) : 107 -121.
  • 6Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study [J]. Neurology, 2011,77(12): 1126-1134.
  • 7Xu W L, yon-Strauss E, Qiu C X, et al. Uncontrolled diabe- tes increases the risk of Alzheimer' s disease: a population- based cohort study[J]. Diabetologia, 2009, 52(6) : 1031 - 1039. DOI : 10. 1007/s00125-009-1323-x.
  • 8Wagner J D, Cline J M, Shadoan M K, et al. Naturally oc- curring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pa- thology[ J ]. Toxicol Pathol, 2001, 29 (1) : 142 - 148.
  • 9Adler B L, Yarchoan M, Hwang H M, et al. Neuroprotec- tive effects of the amylin analogue pramlintide on Alzheimer' s disease pathogenesis and cognition [ J ]. Neurobiol Aging, 2014, 35 (4) : 793 - 801. DOI : 10.1016/j. neurobiolaging. 2013.10.076.
  • 10Jackson K, Barisone G A, Diaz E, et al. Amylin deposition in the brain: a second amyloid in Alzheimer' s disease? [J]. Ann Neurol, 2013, 74(4): 517-526. DOI: 10. 1002/ana. 23956.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部